Clin Mol Hepatol.
2024 Apr;30(2):168-170. 10.3350/cmh.2024.0140.
Clinical impact of five cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease (MASLD): Insights into regional and ethnic differences
- Affiliations
-
- 1Department of Internal Medicine, Nowon Eulji Medical Center, Eulji University College of Medicine, Seoul, Korea
- 2Hanyang Institute of Bioscience and Biotechnology, Hanyang University, Seoul, Korea
- 3Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea
- KMID: 2554422
- DOI: http://doi.org/10.3350/cmh.2024.0140
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Sex differences in metabolic dysfunction-associated steatotic liver disease: a narrative review
- Waiting for the changes after the adoption of steatotic liver disease
- Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity
- Mitochondrial Quality Control: Its Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
- Changing from NAFLD to MASLD: Prevalence and progression of ASCVD risk are similar between NAFLD and MASLD in Asia
